
|Articles|September 1, 2003
BCC DRUG UNDER REVIEW
Photocure ASA's photodynamic therapy, Metvix (methylaminolevulinate) is scheduled for review this month as a basal cell carcinoma treatment.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Envudeucitinib Shows Durable Skin Clearance in Phase 3 Psoriasis Extension
2
The Emerging Role of Oral Peptide Therapeutics in Psoriasis and Beyond
3
Social Media Mythbusters: Hydrocolloid Pimple Patches
4
Allergan Aesthetics Refreshes APP Loyalty Program for Aesthetic Practices
5











